Enhanced antiviral benefit of combination therapy with anti-HBV and anti-PD1 gRNA/cas9 produces a synergistic antiviral effect in HBV infection

Publication date: February 2021Source: Molecular Immunology, Volume 130Author(s): Shuai Zhen, Rong Qiang, Jiaojiao Lu, Xiaoqian Tuo, Xiling Yang, Xu Li
Source: Molecular Immunology - Category: Allergy & Immunology Source Type: research